Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
17 Cards in this Set
- Front
- Back
Why use pharmacological treatment?
|
-Induce Weight Loss
-Maintain Weight Loss -Cost Effectiveness (esp cause might need to not needing drugs for obesity comorbid condition) (BUT don't use drugs as easy way out, or laziness) |
|
History of Pharmacologic treatment
|
often disappointing results serious SEs, underresearched
1890s: thyroid hormone 1930: dinitrophenol 30'-60's: amphetamines (for increased metabolism, addictive tho) |
|
Downsides of Pharmocological treatment
|
Often Ineffective (or modest outcome)
Discontinuation = weight regain Major Side Effects |
|
Phen/Fen Phenomenon
|
(phentermine and fenfluramine)
Popular drug (despite subpar test results) led to valvular heart disease later (= $4 billion in cost of medical monitoring) |
|
Types of weight loss drugs
|
-Reduce energy intake (satiety)
-Reduce nutrient absorption/metabolism (lipases, oxidations up) -Increase energy expenditure |
|
Appetite suppressant drug info, pros/cons
|
alter CNS, dec reuptake Do, NE, HT
-Temporary effect, requires taking before meal -only slightly effective -addictive -SE = nervousness, insomnia, tachycardia, weigh regain |
|
Drugs Reduce Nutrient absorption drugs: block CHO, lipid aborb
|
carb, mostly lipid (about 1/3 eaten) blocked (block lipase)
Alter GI aborbtive sites or enzymes -many side effects: cramping, nausea, diarrhea, steatorrea, leakage, rectal bleeding) |
|
Drugs reduce nutrient absorption: inhibit lipid synthesis/storage
|
decrease FA produce/storage, increase fat oxidation
less side effects, but unknown long-term -High blood pressure |
|
Drugs increase energy expenditure (NONE FDA APPROVED)
|
Enhance thermogenesis/ inc BMR
- tinnitus, prolonged bleeding, GI dmg, inc protein catabolism, > heart size |
|
Anti-obesity drugs on market
|
All Schedule IV or V
(neurotransmitter drugs = IV, only take 12 weeks at time, heart disease/HT esp with sibutramine) ( |
|
Safety Factors of NT drugs
|
-Abuse
-valvular heart disease -primary pulmonary hypertension |
|
Side effects for centrally acting drugs/NT drugs
|
nervous,insomnia, depression,dizzy
headache,nausea,constipation Increase BP and heart rate (but no gastrointestinal issues really at least) |
|
Contraindications (for NT drugs, especially sibutramine)
|
hypertension
on antidepressant, migraine, analgesic meds Coronary artery disease, congestive heart disease, arrhythmias pregnant or a child |
|
Rimonabat (appetite suppress.)
|
Antagonist at cannabinoid 1 receptor, blocks oxigenic effects of endocannabinoids)
-severe psychiatric effect: anxiety, depression (double risk of suicide, thoughts of) |
|
Guidelines prescribing pharmacological treatment:
|
-Approved for maintaining weight loss esp
-(non responder what??) -good for failure to lose/maintain weight -based on clinician judgment |
|
NHLBI criteria for drug use:
|
BMI > 30, or >27 with comorbidity/concomitant risk factors
-Hypertension (HT) -dyslipidemia -Type II diabetes -sleep apnea -osteoarthritis |
|
Proper drug usage
|
For lifestyle change and
Multidisciplinary approach used: (nutrition, exercise, medical, behavior(motivation,habits etc)) |